nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CYP2C9—brain cancer	0.38	1	CbGaD
Melatonin—CYP1B1—Procarbazine—brain cancer	0.248	0.648	CbGbCtD
Melatonin—MPO—Carboplatin—brain cancer	0.0913	0.238	CbGbCtD
Melatonin—CYP1A2—Carmustine—brain cancer	0.0337	0.088	CbGbCtD
Melatonin—CYP1A2—Etoposide—brain cancer	0.00999	0.0261	CbGbCtD
Melatonin—ASMT—pineal body—brain cancer	0.00685	0.068	CbGeAlD
Melatonin—MT3—telencephalic ventricle—brain cancer	0.00537	0.0532	CbGeAlD
Melatonin—SLC22A8—choroid plexus—brain cancer	0.00502	0.0498	CbGeAlD
Melatonin—ASMT—ganglion—brain cancer	0.00492	0.0488	CbGeAlD
Melatonin—MT3—ganglion—brain cancer	0.00334	0.0331	CbGeAlD
Melatonin—MT3—hindbrain—brain cancer	0.00254	0.0251	CbGeAlD
Melatonin—CALM1—trigeminal nerve—brain cancer	0.00223	0.0221	CbGeAlD
Melatonin—CALR—hindbrain—brain cancer	0.002	0.0198	CbGeAlD
Melatonin—ASMT—telencephalon—brain cancer	0.0019	0.0188	CbGeAlD
Melatonin—CALM1—cranial nerve—brain cancer	0.00159	0.0158	CbGeAlD
Melatonin—ASMT—gonad—brain cancer	0.00158	0.0157	CbGeAlD
Melatonin—CALM2—pons—brain cancer	0.00158	0.0156	CbGeAlD
Melatonin—CALM1—pons—brain cancer	0.00157	0.0156	CbGeAlD
Melatonin—MTNR1A—telencephalon—brain cancer	0.00154	0.0153	CbGeAlD
Melatonin—MT3—brainstem—brain cancer	0.00145	0.0144	CbGeAlD
Melatonin—MT3—telencephalon—brain cancer	0.00129	0.0128	CbGeAlD
Melatonin—MTNR1B—head—brain cancer	0.00121	0.012	CbGeAlD
Melatonin—ASMT—endocrine gland—brain cancer	0.0012	0.0119	CbGeAlD
Melatonin—Disorientation—Lomustine—brain cancer	0.00119	0.0196	CcSEcCtD
Melatonin—ASMT—head—brain cancer	0.00118	0.0117	CbGeAlD
Melatonin—CALR—brainstem—brain cancer	0.00115	0.0114	CbGeAlD
Melatonin—NQO2—hindbrain—brain cancer	0.00113	0.0112	CbGeAlD
Melatonin—CALM2—pineal body—brain cancer	0.00113	0.0112	CbGeAlD
Melatonin—CALM1—pineal body—brain cancer	0.00112	0.0111	CbGeAlD
Melatonin—IDO1—endocrine gland—brain cancer	0.00109	0.0109	CbGeAlD
Melatonin—Lethargy—Lomustine—brain cancer	0.00109	0.0179	CcSEcCtD
Melatonin—ASMT—central nervous system—brain cancer	0.00108	0.0107	CbGeAlD
Melatonin—CALR—telencephalon—brain cancer	0.00102	0.0101	CbGeAlD
Melatonin—MT3—medulla oblongata—brain cancer	0.00101	0.01	CbGeAlD
Melatonin—Nocturia—Procarbazine—brain cancer	0.001	0.0165	CcSEcCtD
Melatonin—MPO—endothelium—brain cancer	0.000987	0.00979	CbGeAlD
Melatonin—MTNR1A—head—brain cancer	0.000958	0.0095	CbGeAlD
Melatonin—Visual acuity reduced—Temozolomide—brain cancer	0.000946	0.0156	CcSEcCtD
Melatonin—Agomelatine—CYP2C9—brain cancer	0.000926	1	CrCbGaD
Melatonin—MPO—blood vessel—brain cancer	0.00091	0.00903	CbGeAlD
Melatonin—MT3—spinal cord—brain cancer	0.000903	0.00896	CbGeAlD
Melatonin—Nightmare—Procarbazine—brain cancer	0.000899	0.0148	CcSEcCtD
Melatonin—MTNR1A—central nervous system—brain cancer	0.000875	0.00867	CbGeAlD
Melatonin—ASMT—brain—brain cancer	0.000856	0.00849	CbGeAlD
Melatonin—CALR—gonad—brain cancer	0.000849	0.00842	CbGeAlD
Melatonin—CALR—pituitary gland—brain cancer	0.000828	0.00821	CbGeAlD
Melatonin—MT3—endocrine gland—brain cancer	0.000813	0.00807	CbGeAlD
Melatonin—CALM2—ganglion—brain cancer	0.000808	0.00801	CbGeAlD
Melatonin—CALM1—ganglion—brain cancer	0.000804	0.00798	CbGeAlD
Melatonin—MT3—head—brain cancer	0.000803	0.00796	CbGeAlD
Melatonin—Stomatitis—Lomustine—brain cancer	0.0008	0.0132	CcSEcCtD
Melatonin—CALR—medulla oblongata—brain cancer	0.000799	0.00792	CbGeAlD
Melatonin—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.000762	0.0125	CcSEcCtD
Melatonin—Disorientation—Procarbazine—brain cancer	0.000755	0.0124	CcSEcCtD
Melatonin—Herpes zoster—Temozolomide—brain cancer	0.000748	0.0123	CcSEcCtD
Melatonin—MT3—central nervous system—brain cancer	0.000733	0.00727	CbGeAlD
Melatonin—CALR—midbrain—brain cancer	0.00073	0.00724	CbGeAlD
Melatonin—Memory impairment—Temozolomide—brain cancer	0.000717	0.0118	CcSEcCtD
Melatonin—MT3—cerebellum—brain cancer	0.000716	0.0071	CbGeAlD
Melatonin—CALR—spinal cord—brain cancer	0.000713	0.00707	CbGeAlD
Melatonin—CALM2—endothelium—brain cancer	0.000697	0.00691	CbGeAlD
Melatonin—Nail disorder—Etoposide—brain cancer	0.000694	0.0114	CcSEcCtD
Melatonin—MTNR1A—brain—brain cancer	0.000694	0.00689	CbGeAlD
Melatonin—CALM1—endothelium—brain cancer	0.000694	0.00688	CbGeAlD
Melatonin—Lethargy—Procarbazine—brain cancer	0.00069	0.0114	CcSEcCtD
Melatonin—Disturbance in attention—Temozolomide—brain cancer	0.00065	0.0107	CcSEcCtD
Melatonin—NQO2—brainstem—brain cancer	0.000647	0.00641	CbGeAlD
Melatonin—ESR1—blood vessel—brain cancer	0.000646	0.00641	CbGeAlD
Melatonin—CALM2—blood vessel—brain cancer	0.000643	0.00637	CbGeAlD
Melatonin—CALR—endocrine gland—brain cancer	0.000642	0.00636	CbGeAlD
Melatonin—CALM1—blood vessel—brain cancer	0.00064	0.00634	CbGeAlD
Melatonin—CALR—head—brain cancer	0.000633	0.00628	CbGeAlD
Melatonin—Hyperbilirubinaemia—Temozolomide—brain cancer	0.000619	0.0102	CcSEcCtD
Melatonin—ESR1—hindbrain—brain cancer	0.000617	0.00611	CbGeAlD
Melatonin—CALM2—hindbrain—brain cancer	0.000613	0.00608	CbGeAlD
Melatonin—CALM1—hindbrain—brain cancer	0.00061	0.00605	CbGeAlD
Melatonin—Hepatic enzyme increased—Temozolomide—brain cancer	0.000595	0.0098	CcSEcCtD
Melatonin—Infection—Carboplatin—brain cancer	0.000594	0.00979	CcSEcCtD
Melatonin—Neck pain—Carmustine—brain cancer	0.00059	0.00971	CcSEcCtD
Melatonin—Disorientation—Hydroxyurea—brain cancer	0.000585	0.00963	CcSEcCtD
Melatonin—MT3—brain—brain cancer	0.000582	0.00577	CbGeAlD
Melatonin—CALR—central nervous system—brain cancer	0.000578	0.00573	CbGeAlD
Melatonin—Leukopenia—Lomustine—brain cancer	0.000574	0.00945	CcSEcCtD
Melatonin—NQO2—telencephalon—brain cancer	0.000574	0.00569	CbGeAlD
Melatonin—Angina pectoris—Procarbazine—brain cancer	0.000569	0.00937	CcSEcCtD
Melatonin—CALR—cerebellum—brain cancer	0.000565	0.0056	CbGeAlD
Melatonin—Infection—Lomustine—brain cancer	0.00052	0.00856	CcSEcCtD
Melatonin—Thrombocytopenia—Lomustine—brain cancer	0.000512	0.00844	CcSEcCtD
Melatonin—Pain—Carboplatin—brain cancer	0.000511	0.00842	CcSEcCtD
Melatonin—Stomatitis—Procarbazine—brain cancer	0.000508	0.00836	CcSEcCtD
Melatonin—Haematuria—Procarbazine—brain cancer	0.000497	0.00818	CcSEcCtD
Melatonin—Breast disorder—Hydroxyurea—brain cancer	0.000473	0.00778	CcSEcCtD
Melatonin—NQO2—pituitary gland—brain cancer	0.000467	0.00463	CbGeAlD
Melatonin—CALR—brain—brain cancer	0.000459	0.00455	CbGeAlD
Melatonin—NQO2—medulla oblongata—brain cancer	0.000451	0.00447	CbGeAlD
Melatonin—Hot flush—Temozolomide—brain cancer	0.000437	0.00719	CcSEcCtD
Melatonin—Menopausal symptoms—Temozolomide—brain cancer	0.000433	0.00713	CcSEcCtD
Melatonin—Thirst—Temozolomide—brain cancer	0.000429	0.00707	CcSEcCtD
Melatonin—Hyponatraemia—Carmustine—brain cancer	0.000425	0.00699	CcSEcCtD
Melatonin—NQO2—midbrain—brain cancer	0.000412	0.00409	CbGeAlD
Melatonin—Weight increased—Hydroxyurea—brain cancer	0.000411	0.00678	CcSEcCtD
Melatonin—Mouth ulceration—Etoposide—brain cancer	0.000407	0.00671	CcSEcCtD
Melatonin—Infestation NOS—Hydroxyurea—brain cancer	0.000403	0.00664	CcSEcCtD
Melatonin—Infestation—Hydroxyurea—brain cancer	0.000403	0.00664	CcSEcCtD
Melatonin—Affect lability—Temozolomide—brain cancer	0.000402	0.00662	CcSEcCtD
Melatonin—NQO2—spinal cord—brain cancer	0.000402	0.00399	CbGeAlD
Melatonin—Tension—Procarbazine—brain cancer	0.000399	0.00658	CcSEcCtD
Melatonin—CALM3—telencephalon—brain cancer	0.000397	0.00394	CbGeAlD
Melatonin—Nervousness—Procarbazine—brain cancer	0.000395	0.00651	CcSEcCtD
Melatonin—Stomatitis—Hydroxyurea—brain cancer	0.000393	0.00647	CcSEcCtD
Melatonin—Liver function test abnormal—Carmustine—brain cancer	0.00039	0.00643	CcSEcCtD
Melatonin—Mood swings—Temozolomide—brain cancer	0.000387	0.00638	CcSEcCtD
Melatonin—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000381	0.00628	CcSEcCtD
Melatonin—Dry skin—Temozolomide—brain cancer	0.000375	0.00617	CcSEcCtD
Melatonin—Breast disorder—Temozolomide—brain cancer	0.000369	0.00608	CcSEcCtD
Melatonin—Syncope—Procarbazine—brain cancer	0.000365	0.00601	CcSEcCtD
Melatonin—Leukopenia—Procarbazine—brain cancer	0.000364	0.006	CcSEcCtD
Melatonin—NQO2—endocrine gland—brain cancer	0.000362	0.00359	CbGeAlD
Melatonin—MPO—pituitary gland—brain cancer	0.00036	0.00357	CbGeAlD
Melatonin—Loss of consciousness—Procarbazine—brain cancer	0.000358	0.00589	CcSEcCtD
Melatonin—NQO2—head—brain cancer	0.000357	0.00354	CbGeAlD
Melatonin—ESR1—brainstem—brain cancer	0.000353	0.0035	CbGeAlD
Melatonin—Hypertension—Procarbazine—brain cancer	0.000351	0.00579	CcSEcCtD
Melatonin—CALM2—brainstem—brain cancer	0.000351	0.00348	CbGeAlD
Melatonin—CALM1—brainstem—brain cancer	0.00035	0.00347	CbGeAlD
Melatonin—Arthralgia—Procarbazine—brain cancer	0.000347	0.00571	CcSEcCtD
Melatonin—Anxiety—Procarbazine—brain cancer	0.000345	0.00569	CcSEcCtD
Melatonin—Dry mouth—Procarbazine—brain cancer	0.000339	0.00558	CcSEcCtD
Melatonin—CYP1B1—telencephalon—brain cancer	0.000337	0.00334	CbGeAlD
Melatonin—Vomiting—Lomustine—brain cancer	0.000333	0.00548	CcSEcCtD
Melatonin—Infection—Procarbazine—brain cancer	0.00033	0.00544	CcSEcCtD
Melatonin—Angiopathy—Hydroxyurea—brain cancer	0.000328	0.00541	CcSEcCtD
Melatonin—Shock—Procarbazine—brain cancer	0.000327	0.00538	CcSEcCtD
Melatonin—NQO2—central nervous system—brain cancer	0.000326	0.00323	CbGeAlD
Melatonin—Thrombocytopenia—Procarbazine—brain cancer	0.000325	0.00536	CcSEcCtD
Melatonin—CALM3—pituitary gland—brain cancer	0.000323	0.0032	CbGeAlD
Melatonin—Weight increased—Temozolomide—brain cancer	0.000321	0.00529	CcSEcCtD
Melatonin—NQO2—cerebellum—brain cancer	0.000319	0.00316	CbGeAlD
Melatonin—Stomatitis—Carmustine—brain cancer	0.000318	0.00523	CcSEcCtD
Melatonin—Erythema—Hydroxyurea—brain cancer	0.000315	0.00519	CcSEcCtD
Melatonin—Infestation—Temozolomide—brain cancer	0.000315	0.00519	CcSEcCtD
Melatonin—Infestation NOS—Temozolomide—brain cancer	0.000315	0.00519	CcSEcCtD
Melatonin—ESR1—telencephalon—brain cancer	0.000314	0.00311	CbGeAlD
Melatonin—CALM3—medulla oblongata—brain cancer	0.000312	0.00309	CbGeAlD
Melatonin—CALM2—telencephalon—brain cancer	0.000312	0.00309	CbGeAlD
Melatonin—Nausea—Lomustine—brain cancer	0.000311	0.00512	CcSEcCtD
Melatonin—CALM1—telencephalon—brain cancer	0.00031	0.00308	CbGeAlD
Melatonin—MPO—spinal cord—brain cancer	0.000309	0.00307	CbGeAlD
Melatonin—Stomatitis—Temozolomide—brain cancer	0.000307	0.00506	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000303	0.00498	CcSEcCtD
Melatonin—CYP19A1—gonad—brain cancer	0.000301	0.00299	CbGeAlD
Melatonin—Insomnia—Procarbazine—brain cancer	0.0003	0.00495	CcSEcCtD
Melatonin—Paraesthesia—Procarbazine—brain cancer	0.000298	0.00491	CcSEcCtD
Melatonin—Hepatobiliary disease—Temozolomide—brain cancer	0.000298	0.0049	CcSEcCtD
Melatonin—Somnolence—Procarbazine—brain cancer	0.000295	0.00486	CcSEcCtD
Melatonin—Connective tissue disorder—Carmustine—brain cancer	0.000287	0.00473	CcSEcCtD
Melatonin—Fatigue—Procarbazine—brain cancer	0.000286	0.00472	CcSEcCtD
Melatonin—CALM3—midbrain—brain cancer	0.000285	0.00283	CbGeAlD
Melatonin—Pain—Procarbazine—brain cancer	0.000284	0.00468	CcSEcCtD
Melatonin—Leukopenia—Hydroxyurea—brain cancer	0.000282	0.00464	CcSEcCtD
Melatonin—CYP1B1—gonad—brain cancer	0.000282	0.00279	CbGeAlD
Melatonin—Urinary tract disorder—Temozolomide—brain cancer	0.000279	0.0046	CcSEcCtD
Melatonin—MPO—endocrine gland—brain cancer	0.000279	0.00276	CbGeAlD
Melatonin—CALM3—spinal cord—brain cancer	0.000278	0.00276	CbGeAlD
Melatonin—Connective tissue disorder—Temozolomide—brain cancer	0.000278	0.00458	CcSEcCtD
Melatonin—Urethral disorder—Temozolomide—brain cancer	0.000277	0.00456	CcSEcCtD
Melatonin—MPO—head—brain cancer	0.000275	0.00273	CbGeAlD
Melatonin—CYP1B1—pituitary gland—brain cancer	0.000275	0.00272	CbGeAlD
Melatonin—Eye disorder—Carmustine—brain cancer	0.000273	0.0045	CcSEcCtD
Melatonin—Gastrointestinal pain—Procarbazine—brain cancer	0.000272	0.00447	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000266	0.00439	CcSEcCtD
Melatonin—Eye disorder—Temozolomide—brain cancer	0.000264	0.00435	CcSEcCtD
Melatonin—Abdominal pain—Procarbazine—brain cancer	0.000263	0.00432	CcSEcCtD
Melatonin—Cardiac disorder—Temozolomide—brain cancer	0.000262	0.00432	CcSEcCtD
Melatonin—ESR1—gonad—brain cancer	0.000262	0.0026	CbGeAlD
Melatonin—CALM2—gonad—brain cancer	0.00026	0.00258	CbGeAlD
Melatonin—CALM1—gonad—brain cancer	0.000259	0.00257	CbGeAlD
Melatonin—NQO2—brain—brain cancer	0.000259	0.00257	CbGeAlD
Melatonin—Angiopathy—Temozolomide—brain cancer	0.000256	0.00422	CcSEcCtD
Melatonin—Mental disorder—Carmustine—brain cancer	0.000256	0.00422	CcSEcCtD
Melatonin—Infection—Hydroxyurea—brain cancer	0.000255	0.00421	CcSEcCtD
Melatonin—ESR1—pituitary gland—brain cancer	0.000255	0.00253	CbGeAlD
Melatonin—Immune system disorder—Temozolomide—brain cancer	0.000255	0.00421	CcSEcCtD
Melatonin—Malnutrition—Carmustine—brain cancer	0.000255	0.00419	CcSEcCtD
Melatonin—Erythema—Carmustine—brain cancer	0.000255	0.00419	CcSEcCtD
Melatonin—CALM2—pituitary gland—brain cancer	0.000254	0.00252	CbGeAlD
Melatonin—CALM1—pituitary gland—brain cancer	0.000253	0.00251	CbGeAlD
Melatonin—Nervous system disorder—Hydroxyurea—brain cancer	0.000252	0.00415	CcSEcCtD
Melatonin—Infestation—Etoposide—brain cancer	0.000252	0.00415	CcSEcCtD
Melatonin—Infestation NOS—Etoposide—brain cancer	0.000252	0.00415	CcSEcCtD
Melatonin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000252	0.00415	CcSEcCtD
Melatonin—MPO—central nervous system—brain cancer	0.000251	0.00249	CbGeAlD
Melatonin—Skin disorder—Hydroxyurea—brain cancer	0.00025	0.00411	CcSEcCtD
Melatonin—Mental disorder—Temozolomide—brain cancer	0.000248	0.00408	CcSEcCtD
Melatonin—Back pain—Carmustine—brain cancer	0.000246	0.00406	CcSEcCtD
Melatonin—Erythema—Temozolomide—brain cancer	0.000246	0.00405	CcSEcCtD
Melatonin—Malnutrition—Temozolomide—brain cancer	0.000246	0.00405	CcSEcCtD
Melatonin—Stomatitis—Etoposide—brain cancer	0.000246	0.00405	CcSEcCtD
Melatonin—CALM2—medulla oblongata—brain cancer	0.000245	0.00243	CbGeAlD
Melatonin—Hypersensitivity—Procarbazine—brain cancer	0.000245	0.00403	CcSEcCtD
Melatonin—CALM1—medulla oblongata—brain cancer	0.000244	0.00242	CbGeAlD
Melatonin—Vision blurred—Carmustine—brain cancer	0.00024	0.00395	CcSEcCtD
Melatonin—Asthenia—Procarbazine—brain cancer	0.000238	0.00393	CcSEcCtD
Melatonin—Hepatobiliary disease—Etoposide—brain cancer	0.000238	0.00392	CcSEcCtD
Melatonin—Back pain—Temozolomide—brain cancer	0.000238	0.00392	CcSEcCtD
Melatonin—Pruritus—Procarbazine—brain cancer	0.000235	0.00387	CcSEcCtD
Melatonin—Agitation—Carmustine—brain cancer	0.000234	0.00385	CcSEcCtD
Melatonin—Vision blurred—Temozolomide—brain cancer	0.000232	0.00382	CcSEcCtD
Melatonin—Somnolence—Hydroxyurea—brain cancer	0.000229	0.00376	CcSEcCtD
Melatonin—Leukopenia—Carmustine—brain cancer	0.000228	0.00375	CcSEcCtD
Melatonin—CYP19A1—endocrine gland—brain cancer	0.000228	0.00226	CbGeAlD
Melatonin—Dyspepsia—Hydroxyurea—brain cancer	0.000226	0.00373	CcSEcCtD
Melatonin—Agitation—Temozolomide—brain cancer	0.000226	0.00372	CcSEcCtD
Melatonin—Angioedema—Temozolomide—brain cancer	0.000225	0.0037	CcSEcCtD
Melatonin—CYP19A1—head—brain cancer	0.000225	0.00223	CbGeAlD
Melatonin—CALM2—midbrain—brain cancer	0.000224	0.00222	CbGeAlD
Melatonin—Urinary tract disorder—Etoposide—brain cancer	0.000223	0.00368	CcSEcCtD
Melatonin—CALM1—midbrain—brain cancer	0.000223	0.00221	CbGeAlD
Melatonin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000222	0.00366	CcSEcCtD
Melatonin—Urethral disorder—Etoposide—brain cancer	0.000222	0.00365	CcSEcCtD
Melatonin—Fatigue—Hydroxyurea—brain cancer	0.000222	0.00365	CcSEcCtD
Melatonin—Vertigo—Temozolomide—brain cancer	0.000221	0.00364	CcSEcCtD
Melatonin—CALM3—cerebellum—brain cancer	0.000221	0.00219	CbGeAlD
Melatonin—Leukopenia—Temozolomide—brain cancer	0.00022	0.00363	CcSEcCtD
Melatonin—Hypertension—Carmustine—brain cancer	0.00022	0.00362	CcSEcCtD
Melatonin—Pain—Hydroxyurea—brain cancer	0.00022	0.00362	CcSEcCtD
Melatonin—SLC22A8—head—brain cancer	0.00022	0.00218	CbGeAlD
Melatonin—Dizziness—Procarbazine—brain cancer	0.00022	0.00362	CcSEcCtD
Melatonin—CALM2—spinal cord—brain cancer	0.000218	0.00217	CbGeAlD
Melatonin—Palpitations—Temozolomide—brain cancer	0.000217	0.00358	CcSEcCtD
Melatonin—CALM1—spinal cord—brain cancer	0.000217	0.00216	CbGeAlD
Melatonin—Chest pain—Carmustine—brain cancer	0.000217	0.00357	CcSEcCtD
Melatonin—Anxiety—Carmustine—brain cancer	0.000216	0.00356	CcSEcCtD
Melatonin—CYP1B1—endocrine gland—brain cancer	0.000213	0.00211	CbGeAlD
Melatonin—Hypertension—Temozolomide—brain cancer	0.000212	0.0035	CcSEcCtD
Melatonin—Eye disorder—Etoposide—brain cancer	0.000211	0.00348	CcSEcCtD
Melatonin—Vomiting—Procarbazine—brain cancer	0.000211	0.00348	CcSEcCtD
Melatonin—CYP1B1—head—brain cancer	0.00021	0.00208	CbGeAlD
Melatonin—Cardiac disorder—Etoposide—brain cancer	0.00021	0.00346	CcSEcCtD
Melatonin—Arthralgia—Temozolomide—brain cancer	0.000209	0.00345	CcSEcCtD
Melatonin—Rash—Procarbazine—brain cancer	0.000209	0.00345	CcSEcCtD
Melatonin—Dermatitis—Procarbazine—brain cancer	0.000209	0.00345	CcSEcCtD
Melatonin—Anxiety—Temozolomide—brain cancer	0.000209	0.00344	CcSEcCtD
Melatonin—Headache—Procarbazine—brain cancer	0.000208	0.00343	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000208	0.00343	CcSEcCtD
Melatonin—Infection—Carmustine—brain cancer	0.000206	0.0034	CcSEcCtD
Melatonin—Angiopathy—Etoposide—brain cancer	0.000205	0.00338	CcSEcCtD
Melatonin—CYP19A1—central nervous system—brain cancer	0.000205	0.00203	CbGeAlD
Melatonin—Dry mouth—Temozolomide—brain cancer	0.000205	0.00337	CcSEcCtD
Melatonin—Immune system disorder—Etoposide—brain cancer	0.000204	0.00337	CcSEcCtD
Melatonin—Thrombocytopenia—Carmustine—brain cancer	0.000203	0.00335	CcSEcCtD
Melatonin—SLC22A8—central nervous system—brain cancer	0.000201	0.00199	CbGeAlD
Melatonin—Infection—Temozolomide—brain cancer	0.0002	0.00329	CcSEcCtD
Melatonin—MPO—brain—brain cancer	0.000199	0.00198	CbGeAlD
Melatonin—ESR1—endocrine gland—brain cancer	0.000198	0.00196	CbGeAlD
Melatonin—Nausea—Procarbazine—brain cancer	0.000197	0.00325	CcSEcCtD
Melatonin—Nervous system disorder—Temozolomide—brain cancer	0.000197	0.00324	CcSEcCtD
Melatonin—Thrombocytopenia—Temozolomide—brain cancer	0.000197	0.00324	CcSEcCtD
Melatonin—CALM2—endocrine gland—brain cancer	0.000197	0.00195	CbGeAlD
Melatonin—CALM1—endocrine gland—brain cancer	0.000196	0.00194	CbGeAlD
Melatonin—ESR1—head—brain cancer	0.000195	0.00194	CbGeAlD
Melatonin—Skin disorder—Temozolomide—brain cancer	0.000195	0.00321	CcSEcCtD
Melatonin—CALM2—head—brain cancer	0.000194	0.00192	CbGeAlD
Melatonin—CALM1—head—brain cancer	0.000193	0.00192	CbGeAlD
Melatonin—CYP1B1—central nervous system—brain cancer	0.000192	0.0019	CbGeAlD
Melatonin—Back pain—Etoposide—brain cancer	0.00019	0.00314	CcSEcCtD
Melatonin—Hypersensitivity—Hydroxyurea—brain cancer	0.000189	0.00312	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000189	0.00312	CcSEcCtD
Melatonin—Muscle spasms—Etoposide—brain cancer	0.000189	0.00312	CcSEcCtD
Melatonin—Insomnia—Carmustine—brain cancer	0.000188	0.0031	CcSEcCtD
Melatonin—CYP1B1—cerebellum—brain cancer	0.000187	0.00186	CbGeAlD
Melatonin—CYP2C19—endocrine gland—brain cancer	0.000187	0.00185	CbGeAlD
Melatonin—Paraesthesia—Carmustine—brain cancer	0.000187	0.00307	CcSEcCtD
Melatonin—Somnolence—Carmustine—brain cancer	0.000185	0.00304	CcSEcCtD
Melatonin—Asthenia—Hydroxyurea—brain cancer	0.000184	0.00304	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000183	0.00301	CcSEcCtD
Melatonin—Insomnia—Temozolomide—brain cancer	0.000182	0.00299	CcSEcCtD
Melatonin—Paraesthesia—Temozolomide—brain cancer	0.00018	0.00297	CcSEcCtD
Melatonin—Gastrointestinal disorder—Carmustine—brain cancer	0.000179	0.00295	CcSEcCtD
Melatonin—CALM3—brain—brain cancer	0.000179	0.00178	CbGeAlD
Melatonin—Somnolence—Temozolomide—brain cancer	0.000179	0.00294	CcSEcCtD
Melatonin—ESR1—central nervous system—brain cancer	0.000178	0.00177	CbGeAlD
Melatonin—Pain—Carmustine—brain cancer	0.000178	0.00293	CcSEcCtD
Melatonin—CALM2—central nervous system—brain cancer	0.000177	0.00176	CbGeAlD
Melatonin—Vertigo—Etoposide—brain cancer	0.000177	0.00291	CcSEcCtD
Melatonin—Dyspepsia—Temozolomide—brain cancer	0.000177	0.00291	CcSEcCtD
Melatonin—CALM1—central nervous system—brain cancer	0.000176	0.00175	CbGeAlD
Melatonin—Leukopenia—Etoposide—brain cancer	0.000176	0.0029	CcSEcCtD
Melatonin—ESR1—cerebellum—brain cancer	0.000174	0.00173	CbGeAlD
Melatonin—Gastrointestinal disorder—Temozolomide—brain cancer	0.000173	0.00286	CcSEcCtD
Melatonin—CALM2—cerebellum—brain cancer	0.000173	0.00172	CbGeAlD
Melatonin—Fatigue—Temozolomide—brain cancer	0.000173	0.00285	CcSEcCtD
Melatonin—Loss of consciousness—Etoposide—brain cancer	0.000173	0.00285	CcSEcCtD
Melatonin—CALM1—cerebellum—brain cancer	0.000172	0.00171	CbGeAlD
Melatonin—Pain—Temozolomide—brain cancer	0.000172	0.00283	CcSEcCtD
Melatonin—Hypertension—Etoposide—brain cancer	0.00017	0.0028	CcSEcCtD
Melatonin—Dizziness—Hydroxyurea—brain cancer	0.00017	0.0028	CcSEcCtD
Melatonin—Gastrointestinal pain—Carmustine—brain cancer	0.00017	0.0028	CcSEcCtD
Melatonin—Chest pain—Etoposide—brain cancer	0.000168	0.00276	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000166	0.00274	CcSEcCtD
Melatonin—Abdominal pain—Carmustine—brain cancer	0.000164	0.00271	CcSEcCtD
Melatonin—Gastrointestinal pain—Temozolomide—brain cancer	0.000164	0.0027	CcSEcCtD
Melatonin—Vomiting—Hydroxyurea—brain cancer	0.000163	0.00269	CcSEcCtD
Melatonin—CYP19A1—brain—brain cancer	0.000163	0.00161	CbGeAlD
Melatonin—Rash—Hydroxyurea—brain cancer	0.000162	0.00267	CcSEcCtD
Melatonin—Dermatitis—Hydroxyurea—brain cancer	0.000162	0.00267	CcSEcCtD
Melatonin—Headache—Hydroxyurea—brain cancer	0.000161	0.00265	CcSEcCtD
Melatonin—Infection—Etoposide—brain cancer	0.00016	0.00263	CcSEcCtD
Melatonin—SLC22A8—brain—brain cancer	0.000159	0.00158	CbGeAlD
Melatonin—Abdominal pain—Temozolomide—brain cancer	0.000159	0.00261	CcSEcCtD
Melatonin—Thrombocytopenia—Etoposide—brain cancer	0.000157	0.00259	CcSEcCtD
Melatonin—Skin disorder—Etoposide—brain cancer	0.000156	0.00257	CcSEcCtD
Melatonin—Hypersensitivity—Carmustine—brain cancer	0.000153	0.00252	CcSEcCtD
Melatonin—Nausea—Hydroxyurea—brain cancer	0.000153	0.00251	CcSEcCtD
Melatonin—CYP1A2—endocrine gland—brain cancer	0.000152	0.00151	CbGeAlD
Melatonin—CYP1B1—brain—brain cancer	0.000152	0.00151	CbGeAlD
Melatonin—CYP1A1—endocrine gland—brain cancer	0.00015	0.00149	CbGeAlD
Melatonin—Asthenia—Carmustine—brain cancer	0.000149	0.00246	CcSEcCtD
Melatonin—CYP1A1—head—brain cancer	0.000148	0.00147	CbGeAlD
Melatonin—Hypersensitivity—Temozolomide—brain cancer	0.000148	0.00244	CcSEcCtD
Melatonin—CYP2C9—endocrine gland—brain cancer	0.000145	0.00144	CbGeAlD
Melatonin—Paraesthesia—Etoposide—brain cancer	0.000144	0.00238	CcSEcCtD
Melatonin—Asthenia—Temozolomide—brain cancer	0.000144	0.00237	CcSEcCtD
Melatonin—Somnolence—Etoposide—brain cancer	0.000143	0.00235	CcSEcCtD
Melatonin—Pruritus—Temozolomide—brain cancer	0.000142	0.00234	CcSEcCtD
Melatonin—ESR1—brain—brain cancer	0.000142	0.0014	CbGeAlD
Melatonin—CALM2—brain—brain cancer	0.000141	0.00139	CbGeAlD
Melatonin—CALM1—brain—brain cancer	0.00014	0.00139	CbGeAlD
Melatonin—Gastrointestinal disorder—Etoposide—brain cancer	0.000139	0.00229	CcSEcCtD
Melatonin—Fatigue—Etoposide—brain cancer	0.000139	0.00228	CcSEcCtD
Melatonin—Dizziness—Carmustine—brain cancer	0.000137	0.00226	CcSEcCtD
Melatonin—Pain—Etoposide—brain cancer	0.000137	0.00226	CcSEcCtD
Melatonin—CYP1A1—central nervous system—brain cancer	0.000136	0.00134	CbGeAlD
Melatonin—Dizziness—Temozolomide—brain cancer	0.000133	0.00219	CcSEcCtD
Melatonin—Vomiting—Carmustine—brain cancer	0.000132	0.00218	CcSEcCtD
Melatonin—Gastrointestinal pain—Etoposide—brain cancer	0.000131	0.00216	CcSEcCtD
Melatonin—Rash—Carmustine—brain cancer	0.000131	0.00216	CcSEcCtD
Melatonin—Dermatitis—Carmustine—brain cancer	0.000131	0.00216	CcSEcCtD
Melatonin—Headache—Carmustine—brain cancer	0.00013	0.00214	CcSEcCtD
Melatonin—Vomiting—Temozolomide—brain cancer	0.000128	0.0021	CcSEcCtD
Melatonin—Abdominal pain—Etoposide—brain cancer	0.000127	0.00209	CcSEcCtD
Melatonin—Rash—Temozolomide—brain cancer	0.000127	0.00209	CcSEcCtD
Melatonin—Dermatitis—Temozolomide—brain cancer	0.000127	0.00208	CcSEcCtD
Melatonin—Headache—Temozolomide—brain cancer	0.000126	0.00207	CcSEcCtD
Melatonin—Nausea—Carmustine—brain cancer	0.000123	0.00203	CcSEcCtD
Melatonin—Nausea—Temozolomide—brain cancer	0.000119	0.00196	CcSEcCtD
Melatonin—Hypersensitivity—Etoposide—brain cancer	0.000118	0.00195	CcSEcCtD
Melatonin—Asthenia—Etoposide—brain cancer	0.000115	0.0019	CcSEcCtD
Melatonin—Pruritus—Etoposide—brain cancer	0.000114	0.00187	CcSEcCtD
Melatonin—CYP1A1—brain—brain cancer	0.000108	0.00107	CbGeAlD
Melatonin—Dizziness—Etoposide—brain cancer	0.000106	0.00175	CcSEcCtD
Melatonin—Vomiting—Etoposide—brain cancer	0.000102	0.00168	CcSEcCtD
Melatonin—Rash—Etoposide—brain cancer	0.000101	0.00167	CcSEcCtD
Melatonin—Dermatitis—Etoposide—brain cancer	0.000101	0.00167	CcSEcCtD
Melatonin—Headache—Etoposide—brain cancer	0.000101	0.00166	CcSEcCtD
Melatonin—Nausea—Etoposide—brain cancer	9.55e-05	0.00157	CcSEcCtD
Melatonin—CALM1—Signaling Pathways—GLI1—brain cancer	1.23e-05	0.000166	CbGpPWpGaD
Melatonin—CALM3—Signaling by Wnt—CTNNB1—brain cancer	1.23e-05	0.000165	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—IRS2—brain cancer	1.23e-05	0.000165	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—IRS2—brain cancer	1.23e-05	0.000165	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—IRS2—brain cancer	1.22e-05	0.000164	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—EGFR—brain cancer	1.21e-05	0.000163	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—EGFR—brain cancer	1.21e-05	0.000163	CbGpPWpGaD
Melatonin—CALM3—Signaling by WNT in cancer—MYC—brain cancer	1.21e-05	0.000163	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SUFU—brain cancer	1.2e-05	0.000162	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—PIK3CG—brain cancer	1.2e-05	0.000162	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—PIK3CG—brain cancer	1.2e-05	0.000162	CbGpPWpGaD
Melatonin—CALM1—Signaling by Wnt—CTNNB1—brain cancer	1.19e-05	0.00016	CbGpPWpGaD
Melatonin—CALM2—Signaling by Wnt—CTNNB1—brain cancer	1.19e-05	0.00016	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—IRS2—brain cancer	1.18e-05	0.000159	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—IRS2—brain cancer	1.18e-05	0.000159	CbGpPWpGaD
Melatonin—CALM1—Signaling by WNT in cancer—MYC—brain cancer	1.17e-05	0.000157	CbGpPWpGaD
Melatonin—CALM2—Signaling by WNT in cancer—MYC—brain cancer	1.17e-05	0.000157	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SUFU—brain cancer	1.17e-05	0.000157	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SUFU—brain cancer	1.17e-05	0.000157	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—GFAP—brain cancer	1.16e-05	0.000157	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—STAT3—brain cancer	1.16e-05	0.000157	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CYP2C9—brain cancer	1.15e-05	0.000155	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—BSG—brain cancer	1.14e-05	0.000154	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—GFAP—brain cancer	1.12e-05	0.000151	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—GFAP—brain cancer	1.12e-05	0.000151	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—STAT3—brain cancer	1.12e-05	0.000151	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—STAT3—brain cancer	1.12e-05	0.000151	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—VAV1—brain cancer	1.12e-05	0.000151	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HEY1—brain cancer	1.1e-05	0.000148	CbGpPWpGaD
Melatonin—CALM3—Metabolism—ENO2—brain cancer	1.1e-05	0.000148	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—VAV1—brain cancer	1.09e-05	0.000146	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—VAV1—brain cancer	1.09e-05	0.000146	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—DLL1—brain cancer	1.08e-05	0.000146	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—IDH1—brain cancer	1.08e-05	0.000145	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.07e-05	0.000145	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HEY1—brain cancer	1.07e-05	0.000144	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HEY1—brain cancer	1.07e-05	0.000144	CbGpPWpGaD
Melatonin—CALM2—Metabolism—ENO2—brain cancer	1.06e-05	0.000143	CbGpPWpGaD
Melatonin—CALM1—Metabolism—ENO2—brain cancer	1.06e-05	0.000143	CbGpPWpGaD
Melatonin—ESR1—Generic Transcription Pathway—MYC—brain cancer	1.06e-05	0.000143	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—EGFR—brain cancer	1.06e-05	0.000142	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—DLL1—brain cancer	1.05e-05	0.000141	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—DLL1—brain cancer	1.05e-05	0.000141	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—ENO2—brain cancer	1.04e-05	0.00014	CbGpPWpGaD
Melatonin—CALM3—Immune System—VAV1—brain cancer	1.03e-05	0.000138	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—EGFR—brain cancer	1.02e-05	0.000138	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—EGFR—brain cancer	1.02e-05	0.000138	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—TP53—brain cancer	1.01e-05	0.000137	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—TP53—brain cancer	1.01e-05	0.000137	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NOTCH2—brain cancer	9.98e-06	0.000134	CbGpPWpGaD
Melatonin—CALM3—Signaling by Wnt—MYC—brain cancer	9.95e-06	0.000134	CbGpPWpGaD
Melatonin—CALM2—Immune System—VAV1—brain cancer	9.93e-06	0.000134	CbGpPWpGaD
Melatonin—CALM1—Immune System—VAV1—brain cancer	9.93e-06	0.000134	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—IDH1—brain cancer	9.84e-06	0.000133	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—BSG—brain cancer	9.78e-06	0.000132	CbGpPWpGaD
Melatonin—CALM2—Signaling by Wnt—MYC—brain cancer	9.62e-06	0.00013	CbGpPWpGaD
Melatonin—CALM1—Signaling by Wnt—MYC—brain cancer	9.62e-06	0.00013	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VAV1—brain cancer	9.51e-06	0.000128	CbGpPWpGaD
Melatonin—CALM3—Disease—VAV1—brain cancer	9.48e-06	0.000128	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SHH—brain cancer	9.19e-06	0.000124	CbGpPWpGaD
Melatonin—CALM2—Disease—VAV1—brain cancer	9.17e-06	0.000124	CbGpPWpGaD
Melatonin—CALM1—Disease—VAV1—brain cancer	9.17e-06	0.000124	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SHH—brain cancer	8.89e-06	0.00012	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SHH—brain cancer	8.89e-06	0.00012	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TRPC6—brain cancer	8.86e-06	0.000119	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.79e-06	0.000118	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—IL2—brain cancer	8.75e-06	0.000118	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—RELA—brain cancer	8.75e-06	0.000118	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTCH1—brain cancer	8.71e-06	0.000117	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SMO—brain cancer	8.71e-06	0.000117	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—ERBB2—brain cancer	8.69e-06	0.000117	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TRPC6—brain cancer	8.57e-06	0.000115	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TRPC6—brain cancer	8.57e-06	0.000115	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—ENO2—brain cancer	8.53e-06	0.000115	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—IL2—brain cancer	8.46e-06	0.000114	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—IL2—brain cancer	8.46e-06	0.000114	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—RELA—brain cancer	8.46e-06	0.000114	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—RELA—brain cancer	8.46e-06	0.000114	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTCH1—brain cancer	8.43e-06	0.000114	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTCH1—brain cancer	8.43e-06	0.000114	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SMO—brain cancer	8.43e-06	0.000114	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SMO—brain cancer	8.43e-06	0.000114	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—IDH1—brain cancer	8.41e-06	0.000113	CbGpPWpGaD
Melatonin—CALM3—Immune System—PDGFRA—brain cancer	8.41e-06	0.000113	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—ERBB2—brain cancer	8.41e-06	0.000113	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—ERBB2—brain cancer	8.41e-06	0.000113	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—RELA—brain cancer	8.4e-06	0.000113	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—ERBB2—brain cancer	8.35e-06	0.000112	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HES1—brain cancer	8.18e-06	0.00011	CbGpPWpGaD
Melatonin—CALM3—Disease—HES1—brain cancer	8.15e-06	0.00011	CbGpPWpGaD
Melatonin—CALM1—Immune System—PDGFRA—brain cancer	8.13e-06	0.00011	CbGpPWpGaD
Melatonin—CALM2—Immune System—PDGFRA—brain cancer	8.13e-06	0.00011	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—RELA—brain cancer	8.13e-06	0.000109	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—RELA—brain cancer	8.13e-06	0.000109	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—ERBB2—brain cancer	8.07e-06	0.000109	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—ERBB2—brain cancer	8.07e-06	0.000109	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PIK3CG—brain cancer	8.07e-06	0.000109	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.01e-06	0.000108	CbGpPWpGaD
Melatonin—CALM2—Disease—HES1—brain cancer	7.89e-06	0.000106	CbGpPWpGaD
Melatonin—CALM1—Disease—HES1—brain cancer	7.89e-06	0.000106	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PDGFRA—brain cancer	7.79e-06	0.000105	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ENO2—brain cancer	7.78e-06	0.000105	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PIK3CG—brain cancer	7.77e-06	0.000105	CbGpPWpGaD
Melatonin—CALM3—Disease—PDGFRA—brain cancer	7.76e-06	0.000105	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—CTNNB1—brain cancer	7.61e-06	0.000102	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—SPP1—brain cancer	7.56e-06	0.000102	CbGpPWpGaD
Melatonin—CALM1—Disease—PDGFRA—brain cancer	7.51e-06	0.000101	CbGpPWpGaD
Melatonin—CALM2—Disease—PDGFRA—brain cancer	7.51e-06	0.000101	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—VEGFA—brain cancer	7.44e-06	0.0001	CbGpPWpGaD
Melatonin—CALM3—Immune System—IRS2—brain cancer	7.38e-06	9.94e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—CTNNB1—brain cancer	7.36e-06	9.91e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—CTNNB1—brain cancer	7.36e-06	9.91e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—VEGFA—brain cancer	7.19e-06	9.69e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—VEGFA—brain cancer	7.19e-06	9.69e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IRS2—brain cancer	7.14e-06	9.62e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IRS2—brain cancer	7.14e-06	9.62e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PIK3CG—brain cancer	7.14e-06	9.61e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NOTCH2—brain cancer	6.96e-06	9.38e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PIK3CG—brain cancer	6.9e-06	9.3e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PIK3CG—brain cancer	6.9e-06	9.3e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.85e-06	9.23e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IRS2—brain cancer	6.84e-06	9.21e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—IRS2—brain cancer	6.82e-06	9.18e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NOTCH2—brain cancer	6.74e-06	9.07e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NOTCH2—brain cancer	6.74e-06	9.07e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ENO2—brain cancer	6.65e-06	8.96e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VAV1—brain cancer	6.64e-06	8.94e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—IRS2—brain cancer	6.59e-06	8.88e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—IRS2—brain cancer	6.59e-06	8.88e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VAV1—brain cancer	6.42e-06	8.65e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VAV1—brain cancer	6.42e-06	8.65e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—APC—brain cancer	6.04e-06	8.13e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PIK3CG—brain cancer	6.04e-06	8.13e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—EGFR—brain cancer	6.03e-06	8.12e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—APC—brain cancer	6.02e-06	8.11e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—EGFR—brain cancer	5.83e-06	7.85e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—EGFR—brain cancer	5.83e-06	7.85e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—APC—brain cancer	5.82e-06	7.84e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—APC—brain cancer	5.82e-06	7.84e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—EGFR—brain cancer	5.79e-06	7.79e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HES1—brain cancer	5.71e-06	7.69e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—TP53—brain cancer	5.62e-06	7.57e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—EGFR—brain cancer	5.6e-06	7.54e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—EGFR—brain cancer	5.6e-06	7.54e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HES1—brain cancer	5.52e-06	7.44e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HES1—brain cancer	5.52e-06	7.44e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PDGFRA—brain cancer	5.44e-06	7.32e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—TP53—brain cancer	5.44e-06	7.32e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—TP53—brain cancer	5.44e-06	7.32e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SPP1—brain cancer	5.28e-06	7.11e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PDGFRA—brain cancer	5.26e-06	7.08e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PDGFRA—brain cancer	5.26e-06	7.08e-05	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—MYC—brain cancer	5.11e-06	6.88e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SPP1—brain cancer	5.11e-06	6.88e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SPP1—brain cancer	5.11e-06	6.88e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—RELA—brain cancer	5.09e-06	6.86e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—ERBB2—brain cancer	5.06e-06	6.82e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CG—brain cancer	5.04e-06	6.79e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL2—brain cancer	5.02e-06	6.76e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—RELA—brain cancer	4.93e-06	6.64e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—RELA—brain cancer	4.93e-06	6.64e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—ERBB2—brain cancer	4.9e-06	6.6e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—ERBB2—brain cancer	4.9e-06	6.6e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CG—brain cancer	4.88e-06	6.57e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CG—brain cancer	4.88e-06	6.57e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL2—brain cancer	4.86e-06	6.54e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL2—brain cancer	4.86e-06	6.54e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CG—brain cancer	4.78e-06	6.44e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IRS2—brain cancer	4.77e-06	6.43e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—RELA—brain cancer	4.72e-06	6.36e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—ERBB2—brain cancer	4.69e-06	6.32e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—ERBB2—brain cancer	4.67e-06	6.3e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IRS2—brain cancer	4.62e-06	6.22e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IRS2—brain cancer	4.62e-06	6.22e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL2—brain cancer	4.59e-06	6.18e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—ERBB2—brain cancer	4.52e-06	6.09e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—ERBB2—brain cancer	4.52e-06	6.09e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL2—brain cancer	4.44e-06	5.98e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL2—brain cancer	4.44e-06	5.98e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CTNNB1—brain cancer	4.43e-06	5.97e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CTNNB1—brain cancer	4.28e-06	5.77e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CTNNB1—brain cancer	4.28e-06	5.77e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL2—brain cancer	4.25e-06	5.72e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—APC—brain cancer	4.22e-06	5.68e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CG—brain cancer	4.22e-06	5.68e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CCND1—brain cancer	4.14e-06	5.58e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CTNNB1—brain cancer	4.1e-06	5.53e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CTNNB1—brain cancer	4.09e-06	5.51e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CG—brain cancer	4.08e-06	5.49e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—APC—brain cancer	4.08e-06	5.49e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CG—brain cancer	4.08e-06	5.49e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—APC—brain cancer	4.08e-06	5.49e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CTNNB1—brain cancer	3.96e-06	5.33e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CTNNB1—brain cancer	3.96e-06	5.33e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CG—brain cancer	3.91e-06	5.27e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—STAT3—brain cancer	3.86e-06	5.2e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—EGFR—brain cancer	3.84e-06	5.17e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—STAT3—brain cancer	3.74e-06	5.03e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—STAT3—brain cancer	3.74e-06	5.03e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—EGFR—brain cancer	3.72e-06	5e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—EGFR—brain cancer	3.72e-06	5e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—brain cancer	3.61e-06	4.86e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—STAT3—brain cancer	3.58e-06	4.82e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CG—brain cancer	3.57e-06	4.81e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—STAT3—brain cancer	3.56e-06	4.8e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—EGFR—brain cancer	3.51e-06	4.73e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—STAT3—brain cancer	3.45e-06	4.64e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—STAT3—brain cancer	3.45e-06	4.64e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—EGFR—brain cancer	3.39e-06	4.57e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—EGFR—brain cancer	3.39e-06	4.57e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MYC—brain cancer	3.32e-06	4.48e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MYC—brain cancer	3.31e-06	4.46e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—RELA—brain cancer	3.29e-06	4.44e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ERBB2—brain cancer	3.27e-06	4.41e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EGFR—brain cancer	3.25e-06	4.38e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—EGFR—brain cancer	3.24e-06	4.36e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MYC—brain cancer	3.2e-06	4.32e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MYC—brain cancer	3.2e-06	4.32e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—RELA—brain cancer	3.19e-06	4.29e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—RELA—brain cancer	3.19e-06	4.29e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ERBB2—brain cancer	3.17e-06	4.27e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ERBB2—brain cancer	3.17e-06	4.27e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—EGFR—brain cancer	3.13e-06	4.22e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—EGFR—brain cancer	3.13e-06	4.22e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CG—brain cancer	3.05e-06	4.11e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL2—brain cancer	2.97e-06	4e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCND1—brain cancer	2.89e-06	3.9e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL2—brain cancer	2.87e-06	3.87e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL2—brain cancer	2.87e-06	3.87e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CTNNB1—brain cancer	2.86e-06	3.86e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCND1—brain cancer	2.8e-06	3.77e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCND1—brain cancer	2.8e-06	3.77e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CTNNB1—brain cancer	2.77e-06	3.73e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CTNNB1—brain cancer	2.77e-06	3.73e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—brain cancer	2.73e-06	3.68e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—brain cancer	2.52e-06	3.4e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—STAT3—brain cancer	2.5e-06	3.36e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—brain cancer	2.44e-06	3.29e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—brain cancer	2.44e-06	3.29e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—STAT3—brain cancer	2.41e-06	3.25e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—STAT3—brain cancer	2.41e-06	3.25e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MYC—brain cancer	2.32e-06	3.12e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EGFR—brain cancer	2.27e-06	3.06e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MYC—brain cancer	2.24e-06	3.02e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MYC—brain cancer	2.24e-06	3.02e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EGFR—brain cancer	2.19e-06	2.96e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EGFR—brain cancer	2.19e-06	2.96e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—brain cancer	1.9e-06	2.57e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—brain cancer	1.84e-06	2.48e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—brain cancer	1.84e-06	2.48e-05	CbGpPWpGaD
